4//SEC Filing
Glickman Mark A 4
Accession 0001104659-18-019362
CIK 0001660719other
Filed
Mar 20, 8:00 PM ET
Accepted
Mar 21, 5:15 PM ET
Size
4.9 KB
Accession
0001104659-18-019362
Insider Transaction Report
Form 4
Glickman Mark A
Chief Commercial Officer
Transactions
- Sale
Common Shares, without par value
2018-03-19$1.70/sh−5,725$9,733→ 250,188 total
Footnotes (1)
- [F1]This represents shares sold by the issuer on behalf of the reporting person pursuant to an instruction made in accordance with Rule 10b5-1 for payment of withholding tax liability incurred upon the vesting of 15,184 restricted stock units, which were previously granted on March 17, 2016 and which vested on March 17, 2018.
Documents
Issuer
Aralez Pharmaceuticals Inc.
CIK 0001660719
Entity typeother
Related Parties
1- filerCIK 0001441461
Filing Metadata
- Form type
- 4
- Filed
- Mar 20, 8:00 PM ET
- Accepted
- Mar 21, 5:15 PM ET
- Size
- 4.9 KB